{
    "organizations": [],
    "uuid": "66258acd93239066ea105b4501316c990ae5c58b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-advanced-proteome-therapeutics-and/brief-advanced-proteome-therapeutics-and-immunobiochem-enter-into-collaboration-and-option-agreement-idUSFWN1PX12N",
    "ord_in_thread": 0,
    "title": "BRIEF-Advanced Proteome Therapeutics And Immunobiochem Enter Into Collaboration And Option Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 7 (Reuters) - Advanced Proteome Therapeutics Corp :\n* ADVANCED PROTEOME THERAPEUTICS AND IMMUNOBIOCHEM CORPORATION ENTER INTO A COLLABORATION AND OPTION AGREEMENT\n* ADVANCED PROTEOME THERAPEUTICS - CO, IMMUNOBIOCHEM ENTER INTO COLLABORATION AND OPTION AGREEMENT TO DEVELOP SUPERIOR ANTIBODY-DRUG CONJUGATES\n* ADVANCED PROTEOME THERAPEUTICS - IMMUNOBIOCHEM GRANTED RIGHTS TO LICENSE PROPRIETARY SITE-SELECTIVE CONJUGATION TECHNOLOGY\n* ADVANCED PROTEOME THERAPEUTICS CORP - PRE-NEGOTIATED LICENSING TERMS INCLUDE UPFRONT AND MILESTONE PAYMENTS AND ROYALTIES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-07T21:35:00.000+02:00",
    "crawled": "2018-02-09T05:53:07.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "advanced",
        "proteome",
        "therapeutic",
        "corp",
        "advanced",
        "proteome",
        "therapeutic",
        "immunobiochem",
        "corporation",
        "enter",
        "collaboration",
        "option",
        "agreement",
        "advanced",
        "proteome",
        "therapeutic",
        "co",
        "immunobiochem",
        "enter",
        "collaboration",
        "option",
        "agreement",
        "develop",
        "superior",
        "conjugate",
        "advanced",
        "proteome",
        "therapeutic",
        "immunobiochem",
        "granted",
        "right",
        "license",
        "proprietary",
        "conjugation",
        "technology",
        "advanced",
        "proteome",
        "therapeutic",
        "corp",
        "licensing",
        "term",
        "include",
        "upfront",
        "milestone",
        "payment",
        "royalty",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}